Our results show that these ZIKV neonatal humanized mice display discernible clinical signs of ZIKV infection and restricted development of CD34+ HSC into terminally differentiated B cells thus demonstrating the pathogenic effects of ZIKV on the developing hematopoietic system. Here, CD34 is linked to Zika virus infectious disease.